Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Maze Therapeutics (MAZE) Other Non Operating Income (2024)

Maze Therapeutics has reported Other Non Operating Income over the past 1 years, most recently at -$1.6 million for Q4 2024.

  • Quarterly Other Non Operating Income changed N/A to -$1.6 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was -$1.6 million through Sep 2025, changed N/A year-over-year, with the annual reading at -$8.8 million for FY2024, N/A changed from the prior year.
  • Other Non Operating Income was -$1.6 million for Q4 2024 at Maze Therapeutics, up from -$2.6 million in the prior quarter.
  • Over five years, Other Non Operating Income peaked at $216000.0 in Q2 2024 and troughed at -$4.8 million in Q1 2024.